Candel Therapeutics Inc (NASDAQ:CADL) price closed lower on Monday, February 24, and dropping -5.76% below its previous close.
A look at the daily price movement shows that the last close reads $11.63. Taking into account the 52-week price action we note that the stock hit a 52-week high of $14.60 and 52-week low of $1.34. The stock added 55.24% on its value in the past month.
Candel Therapeutics Inc, which has a market valuation of $487.45 million, is expected to release its quarterly earnings report in March.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give CADL a short term outlook of 100% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Buy, while an average of long term indicators are currently assigning the stock as 50% Buy.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 1 analysts have assigned CADL a recommendation rating as follows: 0 rate it as a Hold; 1 advise Buy while 0 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the Candel Therapeutics Inc (CADL) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Buy, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
The overview shows that CADL’s price is at present 27.84% off the SMA20 and 34.31% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 66.12, with weekly volatility standing at 13.02%. The indicator jumps to 8.16% when calculated based on the past 30 days. Candel Therapeutics Inc (NASDAQ:CADL)’s beta value is holding at -1.32, while the average true range (ATR) indicator is currently reading 0.94.
An analysis of the Candel Therapeutics Inc (NASDAQ:CADL) stock in terms of its daily trading volume indicates that the 3-month average is 4.16 million.
Current records show that the company has 44.48M in outstanding shares. The insiders’ percentage holdings are 27.04% of outstanding shares while the percentage share held by institutions stands at 36.04%. But the 26.27% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
